Anton Berns
- Oncology top 0.1%
- Peptidase Inhibition and Analysis 24
- Cancer-related Molecular Pathways 18
- Molecular Biology top 0.2%
- Epigenetics and DNA Methylation 17
- RNA Interference and Gene Delivery 15
- Immunology top 0.5%
- T-cell and B-cell Immunology 20
- Immune Cell Function and Interaction 18
- Pathology and Forensic Medicine top 0.2%
- Cancer Mechanisms and Therapy 30
- Cancer Research top 0.5%
-
- Virus-based gene therapy research 18
- Co-authors
- Maarten van LohuizenJos JonkersPaul KrimpenfortMartin van der ValkRalph MeuwissenJos DomenMarc VooijsMartin A. van der Valk
- Cited by
- OncologyMolecular BiologyImmunology
- Journals
- Cell (13 papers)Proceedings of the National Academy of Sciences (13 papers)Oncogene (12 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Anton Berns
209 papers receiving 22.9k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 9.6k
- Molecular Biology 13.5k
- Immunology 3.7k
- Pathology and Forensic Medicine 3.1k
- Cancer Research 2.0k
Countries citing papers authored by Anton Berns
This map shows the geographic impact of Anton Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Berns more than expected).
Fields of papers citing papers by Anton Berns
This network shows the impact of papers produced by Anton Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Berns. The network helps show where Anton Berns may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anton Berns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2021 | 28 | |
| 5 | 2019 | 25 | |
| 6 | 2018 | 30 | |
| 7 | 2017 | 19 | |
| 8 | 2015 | 55 | |
| 9 | 2011 | 258 | |
| 10 | 2010 | 25 | |
| 11 | 2010 | 40 | |
| 12 | 2010 | 137 | |
| 13 | 2006 | 40 | |
| 14 | 2004 | 266 | |
| 15 | 2002 | 16 | |
| 16 | 1996 | 250 | |
| 17 | 1996 | 29 | |
| 18 | Requirement for a functional Rb-1 gene in murine developmentbreakdown → | 1992 | 840 |
| 19 | 1973 | 21 | |
| 20 | 1972 | 83 |
About Anton Berns
Anton Berns is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology, having authored 211 papers that have together received 23.7k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (30 papers), Peptidase Inhibition and Analysis (24 papers), T-cell and B-cell Immunology (20 papers), Cancer-related Molecular Pathways (18 papers), Immune Cell Function and Interaction (18 papers), Virus-based gene therapy research (18 papers), Epigenetics and DNA Methylation (17 papers) and RNA Interference and Gene Delivery (15 papers). The work is most often cited by research in Oncology (9.6k citations), Molecular Biology (13.5k citations) and Immunology (3.7k citations). Anton Berns has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Maarten van Lohuizen, Jos Jonkers, Paul Krimpenfort, Martin van der Valk, Ralph Meuwissen, Jos Domen, Marc Vooijs, Martin A. van der Valk, Hein te Riele and Nathalie M. T. van der Lugt. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences, Oncogene, Nature and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.